Literature DB >> 263882

Comparative distribution of gentamicin, tobramycin, sisomicin, netilmicin, and amikacin in interstitial fluid in rabbits.

C Carbon, A Contrepois, S Lamotte-Barrillon.   

Abstract

We compared the penetration of five aminoglycosides into interstitial fluid (IF). IF was obtained in rabbits from Silastic tissue cages. Intramuscular injections were made: 1.5 mg/kg per dose for gentamicin (G), tobramycin (T), sisomicin (S), and netilmicin (N) and 7.5 mg/kg per dose for amikacin (A). Serum levels and IF concentrations were studied for 12 h after a single injection. IF levels were also compared in a six-injection study (one injection every 8 h). Peak serum levels were significantly higher with A than with G, T, S, and N, which gave similar concentrations. In IF, G gave the highest levels 1 h after the first injection. At 4 and 8 h, the concentrations achieved with G and A were similar but significantly greater than those achieved with T, S, and N. Twelve hours after a single injection, N gave higher IF levels than the other drugs except A. In the six-injection study, the IF levels of G and A reached 4.6 +/- 1.5 and 5.27 +/- 1.1 microgram/ml, respectively, at 48 h. S and N gave identical concentrations (2.07 +/- 0.25 and 2.42 +/- 0.42 microgram/ml, respectively). T induced the lowest levels (1.17 +/- 0.30 microgram/ml). Thus, in this rabbit model, the IF concentrations achieved with G and A were above the minimal inhibitory concentrations for most susceptible strains. Possible relations between IF aminoglycoside concentrations and therapeutic efficiency or toxicity are pointed out but deserve further studies.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 263882      PMCID: PMC352247          DOI: 10.1128/AAC.13.3.368

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  [Comparative clinical pharmacology of gentamicin, sisomicin, and tobramycin].

Authors:  H Lode; B Kemmerich; P Koeppe
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  In vitro activity of netilmicin.

Authors:  J A Smith; J R Morgan; M Mogyoros
Journal:  Antimicrob Agents Chemother       Date:  1977-02       Impact factor: 5.191

3.  Comparative nephrotoxicities of netilmicin and gentamicin in rats.

Authors:  F C Luft; M N Yum; S A Kleit
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

4.  Sisomicin versus netilmicin: in vitro susceptibility testing.

Authors:  D J Flournoy
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

5.  Pharmacokinetics of intravenously administered tobramycin in normal volunteers and in renal-impaired and hemodialyzed patients.

Authors:  J C Péchère; R Dugal
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

6.  In vitro studies with netilmicin compared with amikacin, gentamicin, and tobramycin.

Authors:  V Dhawan; E Marso; W J Martin; L S Young
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

Review 7.  Aspects of the pharmacology and toxicology of tobramycin in animals and humans.

Authors:  K S Israel; J S Welles; H R Black
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

8.  In vitro activity of netilmicin, gentamicin, and amikacin.

Authors:  R J Kantor; C W Norden
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

9.  Netilmicin and gentamicin: comparative pharmacology in humans.

Authors:  L J Riff; G Moreschi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

10.  Penetration of cefazolin, cephaloridine, and cefamandole into interstitial fluid in rabbits.

Authors:  C Carbon; A Contrepois; N Brion; S Lamotte-Barrillon
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

View more
  5 in total

1.  Concentrations of various antibiotics in serum and fluids accumulated in diffusion chambers implanted in various sites in rabbits.

Authors:  A Georgopoulos; E Schütze
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

2.  Impact of dosage schedule on the efficacy of gentamicin, tobramycin, or amikacin in an experimental model of Serratia marcescens endocarditis: in vitro-in vivo correlation.

Authors:  G Potel; J Caillon; B Fantin; J Raza; F Le Gallou; J Y Lepage; P Le Conte; D Bugnon; D Baron; H Drugeon
Journal:  Antimicrob Agents Chemother       Date:  1991-01       Impact factor: 5.191

3.  Treatment of LD100 Escherichia coli septic shock with netilmicin and methylprednisolone in baboons.

Authors:  D J Flournoy; L T Archer; B K Beller; R Passey; L B Hinshaw
Journal:  Med Microbiol Immunol       Date:  1986       Impact factor: 3.402

4.  Comparison of venous and capillary blood sampling for the clinical determination of tobramycin serum concentrations.

Authors:  A S Lewis; G Taylor; H O Williams; M H Lewis
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

5.  Non-linear tissue binding of amikacin in rats: the effect of renal impairment.

Authors:  I G Alonso; J M Lanao; M C Saez; A A Dominguez-Gil; A Dominguez-Gil
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Jul-Sep       Impact factor: 2.441

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.